Valid cardiac biochemical markers. Part II

Valid cardiac biochemical markers. Part II

This publication is a continuation of the review of cardiac biomarkers approved by the Food and Drug Administration (USA), including analysis of prospective research, clinical trials and meta-analyses. In the first part, along with data on general concepts, definitions and classification of biomarke...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika 2020-11, Vol.19 (5), p.2588
Hauptverfasser: Gumanova, N. G., Klimushina, M. V., Bogdanova, N. L., Stefanyuk, O. V., Metelskaya, V. A.
Format: Artikel
Sprache:eng
Schlagworte:
atherosclerosis
cardiovascular diseases
circulating biomarkers
coronary artery disease
fda
fibrosis
heart failure
laboratory diagnostics
myocardial infarction
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This publication is a continuation of the review of cardiac biomarkers approved by the Food and Drug Administration (USA), including analysis of prospective research, clinical trials and meta-analyses. In the first part, along with data on general concepts, definitions and classification of biomarkers, diagnostic and prognostic biomarkers of cardiovascular diseases associated with atherosclerosis are studied. In the second part of the review, valid cardiac biomarkers and their diagnostic value in clinical practice are considered.
ISSN:1728-8800
2619-0125
DOI:10.15829/1728-8800-2020-2588